BG BRIDGENE BIOSCIENCES

Serial Number 98155823
686

Registration Progress

Application Filed
Aug 29, 2023
Under Examination
Approved for Publication
Jun 10, 2025
Published for Opposition
Jun 10, 2025
Registered

Trademark Image

BG BRIDGENE BIOSCIENCES

Basic Information

Serial Number
98155823
Filing Date
August 29, 2023
Published for Opposition
June 10, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 10, 2025
Application
Pending
Classes
042

Rights Holder

Bridgene Biosciences, Inc

03
Address
75 Nicholson Ln
San Jose, CA 95134

Ownership History

Bridgene Biosciences, Inc

Original Applicant
03
San Jose, CA

Bridgene Biosciences, Inc

Owner at Publication
03
San Jose, CA

Legal Representation

Attorney
Enshan Hong

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

23 events
Date Code Type Description Documents
Jun 10, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 10, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 4, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 8, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 8, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 8, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 8, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 26, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Sep 26, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Sep 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 26, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Sep 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 27, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 27, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 6, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 6, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 27, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 27, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 26, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 1, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmacological research utilizing biological technology based on structure-based probe design, chemical proteomics, and proteomics mass spectrometer to discover unliganded or undruggable targets from live cells, tissues, and live animals for the purpose of discovering new drugs and developing new drug therapeutics
First Use Anywhere: Nov 9, 2018
First Use in Commerce: Nov 9, 2018

Additional Information

Design Mark
The mark consists of stylized letters "B" and "G" overlapping with each other in a square with rounded corners, to the right of which are words "BRIDGENE BIOSCIENCES".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
BRIDGENE BIOSCIENCES BRIDGENE BIOSCIENCES BRIDGE GENE BIOSCIENCES

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"